Skip to main content
FARMCITY SA logo

FARMCITY SA — Investor Relations & Filings

ISIN · AR0766650987 BYMA Wholesale and retail trade
Open in API
Filings indexed 52 across all filing types
Latest filing 2026-05-15 Board/Management Inform…
Country AR Argentina
Listing BYMA

About FARMCITY SA

https://www.farmacity.com/

FARMCITY SA is a retail company established in 1997, specializing in health, beauty, and wellness. It operates an extensive network of physical stores and an online platform, offering a comprehensive range of products. The company's core offerings include prescription and over-the-counter pharmaceuticals, dermocosmetics, skincare, cosmetics, personal care items, hair care, sun protection, dietary supplements, fragrances, baby products, home essentials, and healthy food. FARMCITY SA aims to provide diverse products and services across multiple categories to enhance customer well-being.

Recent filings

Filing Released Lang Actions
DESIGNACION DIRECTOR TITULAR Y DIRECTORES SUPLENTES
Board/Management Information Classification · 85% confidence The document is a formal ‘Hecho Relevante’ filed with the Comisión Nacional de Valores and local exchanges, announcing the results of the Ordinary General Shareholders’ Meeting held on May 14, 2026, specifically the appointment of a new full director and several alternate directors. This constitutes an announcement of changes in the company’s board of directors, matching the Board/Management Information category.
2026-05-15 Spanish
FEC. CELEB.: 08-05-2026 - TEMA: 5 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Board/Management Information Classification · 80% confidence The document is the minutes (“Acta de Directorio”) of a board of directors meeting of FARMCITY S.A. held on May 8, 2026, detailing internal resolutions including the appointment of a director to sign the interim condensed financial statements. It does not contain the actual interim financial statements, nor is it an earnings release, proxy statement, or legal filing. This is a Board/Management Information document, capturing resolutions and changes in roles/functions at the board level.
2026-05-12 Spanish
FEC. CELEB.: 08-05-2026 - TEMA: 5 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Regulatory Filings Classification · 46% confidence The document is the minutes (“Acta de Directorio”) of a board meeting approving the Company’s interim condensed financial statements for the quarter ended March 31, 2026. It does not itself contain the substantive financial statements or analysis; rather it notes that those statements have been prepared, distributed to directors, and approved for filing with regulators. It is not a board/management change notice (MANG), nor is it the full interim report (IR), but rather a regulatory compliance filing (minutes) that doesn’t fit a more specific category. Therefore, the correct classification is the fallback category for miscellaneous regulatory filings.
2026-05-12 Spanish
NORMA CONTABLE: NIIF - TIPO BALANCE: CONSOLIDADO - PERIODICIDAD: 3 - FECHA CIERRE: 2026-03-31 - ESTADOS CONTABLES - NIIF
Interim / Quarterly Report Classification · 95% confidence The document is titled “Estados Financieros Intermedios Condensados Consolidados” for the three-month period ended March 31, 2026, and includes full financial statements (income, balance sheet, cash flows, changes in equity) along with notes and review report. This is a comprehensive interim (quarterly) financial report, matching the definition of an Interim/Quarterly Report. Q1 2026
2026-05-12 Spanish
NORMA CONTABLE: NIIF - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: 3 - FECHA CIERRE: 2026-03-31 - ESTADOS CONTABLES - NIIF
Interim / Quarterly Report Classification · 91% confidence The document is titled “Estados Financieros Intermedios Condensados Separados” covering the three-month period ended March 31, 2026, and includes full interim condensed financial statements (income statement, balance sheet, statement of changes in equity, cash flows) with notes and auditor review reports. This is a comprehensive interim/quarterly financial report, not merely an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report. Q1 2026
2026-05-12 Spanish
FECHA: 11-05-2026 - OBLIGACIONES NEGOCIABLES (ON) - ART. 10 LON
Capital/Financing Update Classification · 95% confidence The document is a formal “Notice of Issuance” (“Aviso de Emisión”) by Farmacity S.A. regarding the issuance of USD15 million non‐convertible debt under its negotiable obligations program, detailing issue date, terms, interest rate, maturity, approvals, and program information. This is a financing activity announcement (debt issuance), fitting the Capital/Financing Update category.
2026-05-11 Spanish

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.